CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
ASSETS
Property and equipment, net	$ 39,429	$ 40,398
Asset held for sale, net	4,851	4,939
Cash	497	953
Restricted cash	3,005	3,231
Accounts receivable, net of allowances of $2,186 and $2,040	2,034	1,403
Prepaid expenses and other	663	613
Notes receivable	594	1,044
Intangible assets - bed licenses	2,471	2,471
Intangible assets - lease rights, net	74	87
Right-of-use operating lease assets	2,263	2,556
Goodwill	1,585	1,585
Straight-line rent receivable	2,594	2,901
Total assets	60,060	62,181
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
Senior debt, net	39,509	40,401
Debt related to asset held for sale, net	3,354	3,454
Bonds, net	5,849	5,991
Other debt, net	945	889
Accounts payable	3,707	2,493
Accrued expenses	4,703	4,060
Operating lease obligation	2,592	2,917
Other liabilities	1,781	1,791
Total liabilities	62,440	61,996
Stockholders' (deficit) equity:
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 1,890 shares issued and 1,879 shares outstanding at September 30, 2024; and 1,850 shares issued and 1,839 shares outstanding at December 31, 2023	63,144	63,059
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows:
Accumulated deficit	(84,552)	(81,902)
Total stockholders’ equity	(2,380)	185
Total liabilities and stockholders’ equity	60,060	62,181
Series A Preferred Stock
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows:
Preferred stock	426	426
Series B Preferred Stock
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows:
Preferred stock	$ 18,602	$ 18,602